BACKGROUND: Mechanical ventilation (MV) is a predictor of mortality in patients infected with human immunodeficiency virus (HIV) in the intensive care unit (ICU). Patients with HIV-infections are admitted to the ICU for a variety of reasons that frequently require intubation. While survival rates for HIV-infected patients continue to improve, ICU admission rates have remained consistent. METHODS: To observe the consequences of MV in HIV-infected patients, we conducted a retrospective chart review on patients with HIV (n=55) vs. matched HIV-negative patients (n=55) who required MV over a one-year period and compared the groups for differences in outcome and complications. RESULTS: The HIV group had twice the number of deaths (44% vs. 22%, all-cause mortality) (P=0.01). Among the HIV-positive group, 5 of 55 patients required tracheostomy and prolonged MV, compared to 15 of 55 in the control group (9% and 27%, respectively). Successful extubation was virtually identical (47% MV vs. 50% control). Ventilator-associated pneumonia (VAP) was significantly higher among HIV-positive cases (39 of 55 HIV vs. 14 of 55 non-HIV) (P=0.05). Regression analysis revealed that hypotension, hypoalbuminemia, and fever predicted a poorer outcome. Low CD4 cell counts were strongly associated with mortality. CONCLUSION: HIV-infected patients requiring MV have significantly higher mortality and VAP rates than HIV-negative patients. Since VAP is associated with a poor prognosis, discovering ways to prevent it in the HIV-infected patient may improve outcome.
BACKGROUND: Mechanical ventilation (MV) is a predictor of mortality in patients infected with human immunodeficiency virus (HIV) in the intensive care unit (ICU). Patients with HIV-infections are admitted to the ICU for a variety of reasons that frequently require intubation. While survival rates for HIV-infectedpatients continue to improve, ICU admission rates have remained consistent. METHODS: To observe the consequences of MV in HIV-infectedpatients, we conducted a retrospective chart review on patients with HIV (n=55) vs. matched HIV-negative patients (n=55) who required MV over a one-year period and compared the groups for differences in outcome and complications. RESULTS: The HIV group had twice the number of deaths (44% vs. 22%, all-cause mortality) (P=0.01). Among the HIV-positive group, 5 of 55 patients required tracheostomy and prolonged MV, compared to 15 of 55 in the control group (9% and 27%, respectively). Successful extubation was virtually identical (47% MV vs. 50% control). Ventilator-associated pneumonia (VAP) was significantly higher among HIV-positive cases (39 of 55 HIV vs. 14 of 55 non-HIV) (P=0.05). Regression analysis revealed that hypotension, hypoalbuminemia, and fever predicted a poorer outcome. Low CD4 cell counts were strongly associated with mortality. CONCLUSION:HIV-infectedpatients requiring MV have significantly higher mortality and VAP rates than HIV-negative patients. Since VAP is associated with a poor prognosis, discovering ways to prevent it in the HIV-infectedpatient may improve outcome.
Authors: C Alves; J M Nicolás; J M Miró; A Torres; C Agustì; J Gonzalez; A Raño; N Benito; A Moreno; F Garcìa; J Millá; J M Gatell Journal: Eur Respir J Date: 2001-01 Impact factor: 16.671
Authors: H Valdez; T K Chowdhry; R Asaad; I J Woolley; T Davis; R Davidson; N Beinker; B M Gripshover; R A Salata; G McComsey; S B Weissman; M M Lederman Journal: Clin Infect Dis Date: 2000-04-17 Impact factor: 9.079
Authors: F Franzetti; A Grassini; M Piazza; M Degl'innocenti; A Bandera; L Gazzola; G Marchetti; A Gori Journal: Infection Date: 2006-02 Impact factor: 3.553
Authors: D J Cook; S D Walter; R J Cook; L E Griffith; G H Guyatt; D Leasa; R Z Jaeschke; C Brun-Buisson Journal: Ann Intern Med Date: 1998-09-15 Impact factor: 25.391
Authors: Freny J Nirappil; Ana Maheshwari; Joel Andrews; Greg S Martin; Annette M Esper; Sushma K Cribbs Journal: J Crit Care Date: 2014-10-30 Impact factor: 3.425
Authors: Victor Augusto Camarinha de Castro-Lima; Igor C Borges; Daniel Joelsons; Vivian V T Sales; Thais Guimaraes; Yeh Li Ho; Silvia F Costa; Maria Luisa N Moura Journal: Medicine (Baltimore) Date: 2019-06 Impact factor: 1.817